- Home
- PEPG vs MVBF Comparison
PEPG vs MVBF Comparison
Compare PEPG & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PEPG | MVBF |
|---|---|---|
| Founded | 2018 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.6M | 351.9M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | PEPG | MVBF |
|---|---|---|
| Price | $5.88 | $26.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $9.50 | ★ $27.60 |
| AVG Volume (30 Days) | ★ 696.9K | 80.7K |
| Earning Date | 11-12-2025 | 02-12-2026 |
| Dividend Yield | N/A | ★ 2.61% |
| EPS Growth | N/A | ★ 73.99 |
| EPS | N/A | ★ 2.45 |
| Revenue | N/A | ★ $167,853,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $15.22 |
| P/E Ratio | ★ N/A | $10.63 |
| Revenue Growth | N/A | ★ 18.75 |
| 52 Week Low | $0.88 | $15.59 |
| 52 Week High | $6.72 | $28.96 |
Technical Indicators
Market Signals| Indicator | PEPG | MVBF |
|---|---|---|
| Relative Strength Index (RSI) | 58.32 | 42.61 |
| Support Level | $5.19 | $26.00 |
| Resistance Level | $6.72 | $28.96 |
| Average True Range (ATR) | 0.41 | 0.81 |
| MACD | -0.03 | -0.21 |
| Stochastic Oscillator | 89.47 | 8.60 |
Price Performance
Historical ComparisonAbout PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.